BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11166001)

  • 21. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
    Farkouh ME; Kirshner H; Harrington RA; Ruland S; Verheugt FW; Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Gimona A; Matchaba P; Hawkey CJ; Chesebro JH;
    Lancet; 2004 Aug 21-27; 364(9435):675-84. PubMed ID: 15325832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reinitiating aspirin therapy for primary prevention of cardiovascular events in a patient post-aspirin-induced upper gastrointestinal bleed: a case report and review of literature.
    Adly G; Plakogiannis R
    Ann Pharmacother; 2013 Feb; 47(2):e8. PubMed ID: 23386069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical use of aspirin in ischemic heart disease: past, present and future.
    De Caterina R; Renda G
    Curr Pharm Des; 2012; 18(33):5215-23. PubMed ID: 22724410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescription of NSAIDs in patients treatment with platelet inhibitors or anticoagulants].
    Avouac B; Combe B; Darné B
    Presse Med; 2003 Nov; 32(37 Pt 2):S38-43. PubMed ID: 14763353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reasons for resistance to aspirin in cardiovascular disease.
    Szczeklik A; Musiał J; Undas A
    Circulation; 2002 Nov; 106(22):e181-2; author reply e181-2. PubMed ID: 12451018
    [No Abstract]   [Full Text] [Related]  

  • 28. Daily low-dose aspirin: beware of GI bleeding.
    Johns Hopkins Med Lett Health After 50; 2012 Mar; 24(1):6. PubMed ID: 22493823
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspirin resistance: does it exist and is it an important clinical problem?
    Eikelboom J
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoptysis under diclofenac and antiplatelet doses of aspirin.
    Yiannakopoulou EC
    Pharmacology; 2011; 87(1-2):1-4. PubMed ID: 21150234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality?
    Vela Vásquez RS; Peláez Romero R
    Br J Anaesth; 2015 Nov; 115(5):688-98. PubMed ID: 26475800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular events and COX-2 inhibitors.
    McGeer PL; McGeer EG; Yasojima K
    JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735747
    [No Abstract]   [Full Text] [Related]  

  • 34. Aspirin may cut heart disease deaths in women with heart disease.
    Cardiovasc J S Afr; 2006; 17(1):37. PubMed ID: 16547561
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prescription, monitoring of antithrombotic treatment: 1--antiplatelet agents].
    Drouet L
    Rev Prat; 2007 Nov; 57(18):2045-50. PubMed ID: 18326440
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
    Baigent C; Patrono C
    Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
    [No Abstract]   [Full Text] [Related]  

  • 38. COX-2 selective NSAIDs.
    Ryan NS
    Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis.
    Pablos JL
    Arthritis Rheum; 2002 Nov; 46(11):3102. PubMed ID: 12428257
    [No Abstract]   [Full Text] [Related]  

  • 40. The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding.
    Konstantinopoulos PA; Lehmann DF
    J Clin Pharmacol; 2005 Jul; 45(7):742-50. PubMed ID: 15951464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.